Playbooks, reviewer perspectives, templates and demos.
One working knowledge hub, articles, guides, templates, videos and use case demos. Looking for definitions? Browse the glossary →
Why AMNOG is won or lost in the first 90 days
The first 90 days after a positive opinion decide whether you fight from the front foot or spend a year defending claims you never should have made. Here is how the winning teams sequence them.
Inside a NICE submission: what reviewers actually look for
NICE reviewers do not read your submission front-to-back. They triage. Here is the triage list — and the six questions an ex-ERG reviewer says they wrote in the margin of every dossier they ever read.
Indirect treatment comparisons without the hand-waving
The literature on indirect treatment comparisons is honest about its limits. Submissions usually are not. Here is how to pick a method, defend it in writing, and survive the reviewer follow-up.
The investor-ready narrative: Series C in one deck
The Series C deck is not a science talk. It is a sequencing argument. Here is the eight-slide spine the strongest decks share — and the numbers behind each one.
How Knowledgeable thinks about defensible AI
Defensible AI is not a feature we bolted on. It is the entire reason we built Knowledgeable the way we did. Here are the five commitments we make to every customer — and how we audit ourselves against them.
The German AMNOG clock: a week-by-week field guide
A practical week-by-week breakdown of the AMNOG process — what the G-BA reads first, when IQWiG enters, and where senior reviewers fix problems before they become objections.
Reading a NICE FAD without losing the plot
How to read a NICE FAD for what it actually signals — the unspoken pushbacks, the cost-effectiveness sensitivities the committee dwells on, and the precedent it sets for your next submission.
Synthetic control arms: when regulators actually buy them
A field view on synthetic control arms — when FDA and EMA have actually accepted them, what regulators want to see, and how HTA bodies tend to receive them differently.
Pricing corridors for ultra-orphans in 2026
Why ultra-orphan pricing corridors are tightening in 2026 — IRP knock-ons, post-JCA national flexibility, and how to set a launch price that still defends the asset in year three.
What good evidence generation looks like at IND
A pragmatic view on the evidence-generation decisions made at IND that compound into HTA-ready (or HTA-unready) dossiers years later — endpoint choice, comparator strategy, biomarker thinking.
ArticleHTA insights without the headaches: Evidence that shapes decisions
Knowledgeable is revolutionizing Health Technology Assessments (HTA) by creating a structured knowledge base, simplifying data extraction, and empowering consultants with actionable insights for informed market access strategies.
ArticleBuilding Knowledgeable Update 2: Why our launch is AI-free
Great consultancies are built on clarity, evidence, consistency, and trust. AI can accelerate these fundamentals, but only when firms first invest in strong digital foundations.
ArticleClinical trials, decoded: The full picture, in context
Knowledgeable is transforming access to clinical trial data for Market Access consultancies, enhancing decision-making with an AI-driven database that streamlines insights and maximizes operational efficiency.
ArticleHow do top consultancies make each project better than the last?
Consulting quality isn’t built project by project: it compounds. Capturing tacit knowledge, codifying lessons, and creating shared memory turns individual insights into lasting, scalable advantage.
ArticleHow do you find the right data in a sea of noise?
Dr Louise Street-Docherty shares how top consultants cut through information overload: finding relevant, high-quality data fast and aligning teams around clear, evidence-based answers.
ArticleHow do you go from 100 papers to one key insight?
Great consulting means spotting signal in the noise—prioritising relevance, clinical context, and real-world impact over volume, significance, or citations to build strategies that truly resonate.
ArticleHow do you turn a vague brief into a strategic question?
Every great market access project starts with the right question. This Q&A reveals how clarity at scoping saves time, sharpens insights, and drives strategies that resonate.
ArticleHow do you turn raw data into a persuasive story?
Persuasive market access stories don’t just report data, they guide decisions. Clarity comes from focus, alignment, and anchoring every recommendation to evidence that truly matters.
ArticleWhat do you need to know before you start looking?
Market access projects fail when teams chase data without focus. In this Q&A, Louise Street-Docherty shares how structured scoping saves time, sharpens insights, and strengthens strategy.
ArticleWhat makes an insight truly usable to the client?
Turning insight into influence means more than collecting data. It requires clarity, defensibility, and tailored storytelling that equips every client stakeholder to act with confidence.
ArticleWhy does knowing who said it matter just as much as what they said?
Finding real influence in market access means looking past publication counts to ask: who truly shapes payer decisions, connects networks, and carries weight in the right regions?
ArticleBuilt for output: How project templates bring strategy into focus
Knowledgeable's project templates streamline Market Access consultancy, reducing ambiguity and enhancing efficiency. This empowers consultants to focus on strategic insights, delivering high-quality, client-aligned outcomes consistently.
ArticleMaking teamwork work: How structure drives consistency in market access
Knowledgeable offers an AI-enhanced operating system for market access consultancies, ensuring structured collaboration, consistency in workflows, and improved efficiency, ultimately driving successful project outcomes and strategic insights.
ArticleSecuring the edge: Why access control is critical for modern market access work
Access control is vital for market access consultancies to protect sensitive data and foster collaboration. Knowledgeable's AI platform enhances security, ensuring robust protocols for informed decision-making and client trust.
ArticleWhat if you never lost a good idea again?
Knowledgeable advances Market Access consulting by creating a centralized knowledge memory system, enhancing collaboration, retention, and efficiency, ensuring valuable insights and ideas are never lost amid team transitions.
ArticleWhy start from scratch? How modular frameworks save time and elevate quality
Knowledgeable's AI-enhanced operating system utilizes modular frameworks to streamline consulting processes, ensuring efficient, high-quality outputs and fostering collaboration in market access consulting. Embrace innovation for enduring client insights.
ArticleBuilding Knowledgeable Update 1: We’re not here to overpromise
A behind-the-scenes look at how we’re building our AI-enhanced operating system for Strategic Market Access consultancies with rigor, transparency, and real-world accountability.
Article250 million papers, one single truth: only the right ones matter
Our platform transforms evidence gathering in pharma and health by utilizing AI to streamline searches through over 250 million publications, enabling efficient access and analysis of critical knowledge.
ArticleAuthor lists to influence maps: understanding who shapes the science
Explore enhanced influence mapping in healthcare through enriched expert profiles and AI-driven insights. Understand key opinion leaders and their roles to develop targeted, evidence-based strategies for better stakeholder engagement.
ArticleBecause names matter: How author disambiguation supercharges scientific insight
In an era where AI promises speed and scale, market access consultants still face one stubborn bottleneck: knowing who to trust.
ArticleProfit is hiding in your process: The three biggest efficiency leaks in your consulting workflow
If you’ve been in market access consulting long enough, you know this truth: great people can’t overcome broken systems forever.
ArticleRanking matters: The critical flaw in how most AI handles market access data
The biggest misconception about AI is that finding information is the same as understanding it. It’s not. Consultants don’t just gather data. They weigh it.
ArticleSignal over noise: How the right ontology makes AI work for Market Access
Market access consultants face a paradox: there’s more data than ever—but turning it into strategic insight is harder than ever.
ArticleThe silent squeeze: How pharma’s ‘do more with less’ culture is reshaping the consultancy business model
Pharma is under pressure. Their answer? Push more work downstream, demand it faster, and expect the same (or higher) standard for less.
ArticleConsultancy burnout is a system problem, not a people problem
In consulting, there’s a long-standing myth: the best people are the ones who can take on more. More timelines. More fire drills. More deliverables.
ArticleEvery proposal is a bet: Why consultancies can’t afford to lose time on speculative work
Most market access firms underestimate the resource drain of speculative work. A typical proposal isn’t just a quote and a few paragraphs. It’s a crafted narrative. A mini-strategy.
ArticleExplainable AI in market access: What it is, why it matters, and how to get it right
Most AI feels like magic until it goes wrong. It gives you a paragraph, an answer, a draft GVD section… and it looks great. But then someone asks a perfectly fair question. “What’s this based on?”
ArticleThe hidden cost of rework: Why knowledge loss is killing profitability in market access consulting
Most consultancies don’t realise how much time they’re losing to rework, because it doesn’t show up on a single line in the P&L.
ArticleWhy generic AI won’t fix Market Access consulting… and might even make it worse
Market access work is a mix of clinical nuance, pricing context, regulatory frameworks, and payer logic. It lives in long-form documents, regional value statements, stakeholder maps, and years of strategic knowledge that isn’t public and isn’t always consistent.
ArticleWhy market access consulting is now a three-dimensional challenge, and what to do about it
Once upon a time, market access consulting was tough but manageable. Now it’s become a three-dimensional challenge and every axis is working against you.
ArticleGrounded AI: How next-gen retrieval unlocks strategic clarity in Market Access
Without compromising quality or compliance market access teams are under pressure to deliver more strategy, faster. So all aboard the AI hype train? Not so fast!
ArticleProof in practice: How attribution transforms market access strategy
In market access consulting, trust is earned with more than just good ideas, it’s proven with traceable insight.
Plain-English definitions for AMNOG, ICER, JCA, ITC/MAIC, RWE and the rest of the vocabulary teams actually use.